Clinical Trial

Syntrillo Telehealth Stroke Risk Reduction Study

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Insufficient enrollment
Summary
A prospective, single-arm, open-label study evaluating the impact of Syntrillo's telehealth program on stroke risk factors, particularly blood pressure, among 68 high-risk patients. The 6-month intervention includes personalized remote care with blood pressure monitoring, wearable tracking, and multidisciplinary telehealth visits.
Protocol Amendment History 5 changes
critical Trial status changed: Not Yet Recruiting → Terminated 2026-07-31
critical Trial terminated: Insufficient enrollment 2026-07-31
notable Enrollment reduced: 68 -> 11 participants 2026-07-31
notable Primary completion pushed: 2026-03 -> 2026-07-22 2026-07-31
minor Completion pushed: 2026-05 -> 2026-07-22 2026-07-31
Trial Details
NCT Number NCT07124728
Lead Sponsor Syntrillo, Inc
Conditions Hypertension, Hypertension (HTN), Stroke Prevention, Cardiovascular Risk Factor
Enrollment 11 participants
Start Date 2025-07-30
Primary Completion 2026-07-22 (estimated)
Study Completion 2026-07-22 (estimated)
Updated on ClinicalTrials.gov 2026-07-30